Cited by 797Metabolism, Diabetes, and CancerBiochemical and Molecular ResearchPI3K/AKT/mTOR signaling in cancer

AMPK signalling in health and disease

Open access
Carling, David·2017·Current Opinion in Cell Biology

Abstract

In eukaryotic cells AMP-activated protein kinase (AMPK) plays a major role in regulating cellular energy balance. AMPK responds to changes in intracellular adenine nucleotide levels, being activated by an increase in AMP/ADP relative to ATP. Activation of AMPK increases the rate of catabolic (ATP-generating) pathways and decreases the rate of anabolic (ATP-utilising) pathways. In addition to its role in maintaining intracellular energy balance, AMPK regulates whole body energy metabolism. Given its key role in controlling energy homeostasis, AMPK has attracted widespread interest as a potential therapeutic target for metabolic diseases, including type 2 diabetes and, more recently, cancer. Here I review the regulation of AMPK and its potential as a target for therapeutic intervention in human disease.

Integrity signals

Registry

Crossref · 10.1016/j.ceb.2017.01.005

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Carling, D.
Affiliations
Hammersmith Hospital (GB)
Corresponding author
Carling, David
Venue
Current Opinion in Cell Biology
Publisher
Elsevier BV
Published
2017-04
Volume
45
Pages
31-37
ISSN
0955-0674 (ISSN-L)
OpenAlex
W2589445559
Cited by
797
References
6
Citations by year
2026: 60 · 2025: 90 · 2024: 107 · 2023: 102 · 2022: 137 · 2021: 102 · 2020: 83 · 2019: 49 · 2018: 38 · 2017: 29
FWCI
5.09
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Cell Biology (publishedVersion)
  • PubMed (publishedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
Funders
  • Medical Research Council
  • BBSRC/CASE PhD studentship award in collaboration with AstraZeneca
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
AMPK, AMPK signaling, cellular energy homeostasis, metabolic disorders, type 2 diabetes, cancer, therapeutic target
MeSH terms
Animals, Energy Metabolism, Homeostasis, Humans, Metabolic Diseases, Neoplasms, Signal Transduction, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review